GENEVA, July 6 -- RINUAGENE BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/144561) for “MRNA DELIVERY SYSTEM FOR ENHANCING PROTEIN EXPRESSION AND USE THEREOF”. With publication no. WO/2026/138760, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/67
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....